ABOUT US

Developping innovative in-vitro kits for the ADME-Tox segment

What We Do

We develop, implement and commercialize cell-based ready-to-use kits that provide reliable results reducing time and costs. Pharmaceutical and biotech companies can use human and material resources more efficiently, while optimizing the development cycle for new drugs.

Our R&D department works on the expansion of our product portfolio, with the aim of developing new tools that fulfill the needs of the pharmaceutical industry. By offering a diversity of R&D service, we offer our expertise, know-how, technical & human resources to develop ad-hoc solutions.